- Report
- November 2024
Global
From €6826EUR$7,500USD£5,852GBP
- Report
- November 2024
Global
From €6826EUR$7,500USD£5,852GBP
- Report
- February 2025
- 52 Pages
Global
From €6826EUR$7,500USD£5,852GBP
- Report
- February 2025
- 52 Pages
Global
From €6826EUR$7,500USD£5,852GBP
- Report
- March 2025
- 138 Pages
Global
From €3973EUR$4,365USD£3,406GBP
€4414EUR$4,850USD£3,784GBP
- Report
- July 2024
- 125 Pages
United States
From €5415EUR$5,950USD£4,642GBP
- Report
- September 2020
- 235 Pages
Global
From €4459EUR$4,899USD£3,822GBP
- Report
- December 2022
- 325 Pages
Global
From €4769EUR$5,423USD£3,950GBP
- Report
- February 2023
- 159 Pages
Europe
From €3185EUR$3,500USD£2,731GBP
- Report
- February 2023
- 266 Pages
Global
From €3822EUR$4,200USD£3,277GBP
- Report
- July 2022
- 274 Pages
Global
From €3185EUR$3,500USD£2,731GBP
- Report
- June 2022
- 294 Pages
Global
From €3185EUR$3,500USD£2,731GBP
- Report
- October 2023
- 207 Pages
India
From €1797EUR$1,975USD£1,541GBP
€3595EUR$3,950USD£3,082GBP
- Report
- July 2023
- 284 Pages
Global
From €2503EUR$2,750USD£2,146GBP
€5006EUR$5,500USD£4,291GBP
- Report
- October 2023
- 177 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2023
- 190 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2024
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- February 2024
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- April 2023
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- January 2022
- 110 Pages
Global
From €4323EUR$4,750USD£3,706GBP

The Viral Infection market within the context of Infectious Disease Testing is a rapidly growing sector of the healthcare industry. It is focused on the development of tests that can detect the presence of viruses in a patient's body. These tests are used to diagnose and monitor the progression of viral infections, such as influenza, HIV, and hepatitis. They can also be used to detect the presence of other infectious agents, such as bacteria and fungi.
The Viral Infection market is driven by the increasing prevalence of viral infections, as well as the need for more accurate and timely diagnosis. The development of new technologies, such as next-generation sequencing and PCR-based assays, has enabled the development of more sensitive and specific tests. This has led to the emergence of a number of companies offering a range of tests for the detection of viral infections.
Some of the major companies in the Viral Infection market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. These companies offer a range of tests for the detection of viral infections, including PCR-based assays, ELISA-based assays, and next-generation sequencing-based assays. Show Less Read more